Renal cell carcinoma constitutes 3% of all adult malignancies and often presents insidiously with vague abdominal symptoms. It has a variable natural course and metastatic involvement of the lung, lymph nodes, liver, bone, adrenal glands, kidney, brain, heart, spleen, intestine, and skin is usually seen in descending order of frequency. However, the duodenum is an uncommon site for metastasis from renal cell carcinoma. Consequently, diagnosis and an appropriate treatment are often delayed because of rarity of this type of metastatic involvement. Thorough endoscopic evaluation of the upper small intestine and a high index of suspicion are vital for correct diagnosis and appropriate management of this type of metastatic involvement.
Duodenal Metastasis from Renal Cell Carcinoma presenting as Gastrointestinal Bleed
Departments of Radiation Oncology, Surgical Gastroenterology, and Clinical Haematology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar-190011, Kashmir, India Malignant causes account for 1-4% of upper gastrointestinal bleeding (GI-bleed). In absence of widespread nodal and visceral metastatic disease, isolated duodenal metastasis from renal cell carcinoma (RCC) is very rare. Consequently, gastrointestinal bleeding from renal cell carcinoma metastases is an infrequent and often un-recognized manifestation of this disease.
Here, we describe case of a 52 year-old man in whom metastasis arising from renal cell carcinoma developed in the duodenum 8 years after nephrectomy as the first relapse. The patient presented with severe anemia due to occult GI bleed. The diagnosis was confirmed by endoscopic biopsy and immuno-histochemistry (IHC).Palliative local resection of the tumor was attempted, however, patient had progression of the disease and developed liver metastasis with pleural effusion and succumbed to his disease.
Since, late recurrence/metastasis is characteristic of renal cell carcinoma, careful long-term follow-up is needed to pick up an early relapse. To our knowledge, this is the 20th case of duodenal metastasis from RCC and the first case from Kashmir valley of Indian sub-continent reported in literature. JMS 2012;15(1):65-68.
Key Words: Duodenal metastasis, renal cell carcinoma, GI bleed . As a last resort palliative radiotherapy to duodenal metastatic tumor was planned but patient refused and was discharged on request-(died at home one week later).
Discussion
Renal cell carcinoma represents 3% of all adult malignancies. It has an un-predictable behavior and varied range of clinical manifestations. Approximately, 25-30% of patients examination revealed full field RBCs and abdominal ultrasound examination revealed an iso-echoic right renal mass. A contrast CT scan examination conducted in May, 2000 revealed an iso-dense moderately enhancing mass replacing upper 2/3rd of right kidney with early changes of central necrosis. Peri-renal fascia and inferior vena-cava were normal. There was no regional lymphadenopathy ( Figure  1 ).The patient underwent right radical nephrectomy.
Operative findings were consistent with T2, N0 status. Histopathology of the specimen revealed features of renal cell carcinoma with intact capsule without any vascular and/or lymphatic infiltration. Metastatic work-up confirmed M0 status and patient was put on regular follow-up at 3-6 monthly intervals with X-ray chest, urine examination, abdominal ultrasound and bone scan examinations. Patient remained disease free till August, 2008 when he presented with severe anemia with hemoglobin value of 4 gms/dl. He was admitted for evaluation and supportive care. His bone scan, X-ray chest, an ultra-sound examination of abdomen/ Journal of Medical Sciences 2012;15(1):65-68 toms are non-specific and diagnosis may get delayed. Our patient presented with severe anemia associated with occult GI bleed and at his terminal stage he developed metastatic liver involvement and pleural effusion as well. Majority of RCC patients are found to have metastasis within a year or two after nephrectomy though cases metastising to duodenum/pancreas have been reported after 13 and 27 years 3, 8, 9 latency period. In the index case duodenal metastasis developed 8 years after nephrectomy showing thereby the quiescent and very un-predictable natural history of the disease. A prolonged latent interval from nephrectomy to 9 metastatic event seems to confer a better prognosis. However, this did not happen in our patient in whom the disease behaved very aggressively with metastatic involvement of liver and pleural effusion resulting in a rapid downhill course. Treatment options in a case of RCC metastasis depend upon the extent and location of the lesion. In the majority of reported cases of duodenal metastasis, metastatectomy was 10 performed. In the index case palliative metastatectomy was performed but fast re-growth of the residual disease was noticed with later fulminant wide spread metastatic disease. We did not attempt arterial embolization in our patient though it has been tried in such presentation. Patient was given option of interferon/interleukin-2/sunitinib but he refused. It is known that treatment even with these modalities yields poor survival in patients with wide spread metastatic disease with average survival of about 4 months and 11 only 10% of these survive for one year.
Conclusion
Gastrointestinal bleeding from duodenal metastasis may present with frank hematemesis or signs of occult blood loss or intestinal obstruction. Due to its rarity, duodenal metastasis in RCC is often not suspected leading to delayed diagnosis and clinical deterioration of patient. The present report highlights the importance of investigating patients of RCC presenting with any gastro-intestinal tract manifestations for metastasis particularly in pancreatico-duodenal areas. A complete evaluation, especially endoscopic examination and biopsy, needs to be carried out in such patients. Awareness of this type of presentation and a high index of suspicion on the part of treating physician/oncologist and pathologist would help in making a proper diagnosis and 
